Literature DB >> 25547835

Functional expression of L-lysine α-oxidase from Scomber japonicus in Escherichia coli for one-pot synthesis of L-pipecolic acid from DL-lysine.

Yasushi Tani1, Ryoma Miyake, Ryoichi Yukami, Yasumasa Dekishima, Hideyasu China, Shigeki Saito, Hiroshi Kawabata, Hisaaki Mihara.   

Abstract

L-Pipecolic acid is a key component of biologically active molecules and a pharmaceutically important chiral building block. It can be stereoselectively produced from L-lysine by a two-step bioconversion involving L-lysine α-oxidase and ∆(1)-piperideine-2-carboxylae (Pip2C) reductase. In this study, we focused on an L-lysine α-oxidase from Scomber japonicus that was originally identified as an apoptosis-inducing protein (AIP) and applied the enzyme to one-pot fermentation of L-pipecolic acid in Escherichia coli. A synthetic gene coding for an AIP was expressed in E. coli, and the recombinant enzyme was purified and characterized. The purified enzyme was determined to be a homodimer with a molecular mass of 133.9 kDa. The enzyme essentially exhibited the same substrate specificity as the native enzyme. Optimal temperature and pH for the enzymatic reaction were 70 °C and 7.4, respectively. The enzyme was stable below 60 °C and at a pH range of 5.5-7.5 but was markedly inhibited by Co(2+). To establish a one-pot fermentation system for the synthesis of optically pure L-pipecolic acid from DL-lysine, an E. coli strain carrying a plasmid encoding AIP, Pip2C reductase from Pseudomonas putida, lysine racemase from P. putida, and glucose dehydrogenase from Bacillus subtilis was constructed. The one-pot process produced 45.1 g/L of L-pipecolic acid (87.4 % yield from DL-lysine) after a 46-h reaction with high optical purity (>99.9 % enantiomeric excess).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547835     DOI: 10.1007/s00253-014-6308-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

Review 1.  Expanding lysine industry: industrial biomanufacturing of lysine and its derivatives.

Authors:  Jie Cheng; Peng Chen; Andong Song; Dan Wang; Qinhong Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-04-13       Impact factor: 3.346

Review 2.  Our microbes not only produce antibiotics, they also overproduce amino acids.

Authors:  Sergio Sanchez; Romina Rodríguez-Sanoja; Allison Ramos; Arnold L Demain
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  An economically and environmentally acceptable synthesis of chiral drug intermediate L-pipecolic acid from biomass-derived lysine via artificially engineered microbes.

Authors:  Jie Cheng; Yuding Huang; Le Mi; Wujiu Chen; Dan Wang; Qinhong Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-05-10       Impact factor: 3.346

4.  Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.

Authors:  Hanxiao Ying; Sha Tao; Jing Wang; Weichao Ma; Kequan Chen; Xin Wang; Pingkai Ouyang
Journal:  Microb Cell Fact       Date:  2017-03-27       Impact factor: 5.328

5.  Structural Basis for Recognition of L-lysine, L-ornithine, and L-2,4-diamino Butyric Acid by Lysine Cyclodeaminase.

Authors:  Kyungjin Min; Hye-Jin Yoon; Atsushi Matsuura; Yong Hwan Kim; Hyung Ho Lee
Journal:  Mol Cells       Date:  2018-04-05       Impact factor: 5.034

6.  An Artificial Pathway for N-Hydroxy-Pipecolic Acid Production From L-Lysine in Escherichia coli.

Authors:  Zhou Luo; Zhen Wang; Bangxu Wang; Yao Lu; Lixiu Yan; Zhiping Zhao; Ting Bai; Jiamin Zhang; Hanmei Li; Wei Wang; Jie Cheng
Journal:  Front Microbiol       Date:  2022-03-08       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.